Harvey, O., Parrish, M., van Teijlingen, E. and Trenoweth, S., 2022. Libido as a motivator for starting and restarting non-prescribed anabolic androgenic steroid use among men: a mixed-methods study. Drugs: Education, Prevention and Policy, 29 (3), 276-288.
Full text available as:
|
PDF
DEPP Libido Article Anon Revised post 2nd review Final.pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial. 321kB | |
Copyright to original material in this document is with the original owner(s). Access to this content through BURO is granted on condition that you use it only for research, scholarly or other non-commercial purposes. If you wish to use it for any other purposes, you must contact BU via BURO@bournemouth.ac.uk. Any third party copyright material in this document remains the property of its respective owner(s). BU grants no licence for further use of that third party material. |
DOI: 10.1080/09687637.2021.1882940
Abstract
Anabolic Androgenic Steroids (AAS) are commonly used for their anabolic effects and potential detrimental consequences are well documented. Most studies focus on the motivations of increased muscle development and report increased libido as a secondary motivation. This paper aims to explore users’ reports of libido as a motivator for starting and restarting AAS use. This mixed-methods study comprised questionnaires with 133 adult male AAS users (38% of selected increased libido as motivation for using), and 23 semi-structured interviews with a sub-sample. Thematic analysis identified four interlinked themes: increased libido as a motivation for starting/re-starting AAS; increased libido/sexual performance as a beneficial effect; mixed experiences with physicians regarding libido changes and hypogonadism and reduced sexual functioning and fertility after AAS cessation. Increased libido was identified as a benefit by 90% but motivations for use changed over time. Reasons for AAS use included mitigating the effects of aging particularly linked to the concept of virility. AAS as self-medication for low testosterone needs further investigation as does the idea of hegemonic masculinity as a reinforcing driver for AAS use. This study highlights the need to consider how AAS users’ views of medical support impact on self-medication choices.
Item Type: | Article |
---|---|
ISSN: | 0968-7637 |
Uncontrolled Keywords: | Anabolic androgenic steroids (AAS); libido; low testosterone; low mood; sexual function; Testosterone Replacement Therapy (TRT) |
Group: | Faculty of Health & Social Sciences |
ID Code: | 35180 |
Deposited By: | Symplectic RT2 |
Deposited On: | 09 Feb 2021 13:12 |
Last Modified: | 12 Jul 2022 14:19 |
Downloads
Downloads per month over past year
Repository Staff Only - |